Clinical Trial Update: Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine in children with relapsed or refractory acute lymphoblastic leukemia or acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Phase 2 | Status: COMPLETED